ANDREA L RICHARDSON, MD PHD
Medical Practice in Boston, MA
License number
Massachusetts 151790
Category
Medical Practice
Type
Cytopathology
License number
Massachusetts 151790
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
2
75 Brigham And Womens Hospital Department Of Pathology, Boston, MA 02115
111 Cypress St, Brookline, MA 02445
111 Cypress St, Brookline, MA 02445
Phone
(617) 732-4764
(617) 582-1200
(617) 582-1200
Personal information
See more information about ANDREA L RICHARDSON at radaris.comName
Address
Phone
514 Weld St, West Roxbury, MA 02132
3 Myles Standish Dr UNIT 5, Haverhill, MA 01835
Professional information
Interior Designer
Position:
Designer at Heritage Design, Web Designer at Andrea Richardson, LLC, Customer Service Trainer at Bed Bath & Beyond
Location:
Greater Boston Area
Industry:
Design
Work:
Heritage Design
since May 2007
-
Designer
Andrea Richardson, LLC
since May 2009
-
Web Designer
Bed Bath & Beyond
since May 2009
-
Customer Service Trainer
Cohasset Swim Center
Aug 2004 - Aug 2007
-
Head Lifeguard
Education:
Pratt Institute 2006 - 2010
Bachelors of Fine Arts, Interior Design DIS 2009 - 2009
Bachelors of Fine Arts, Interior Design DIS 2009 - 2009
Skills:
AutoCAD, Revit, Photoshop, Dreamweaver, InDesign, Illustrator, Adobe Bridge, 3D Studio Max, Model Making, Microsoft Word, Microsoft Excel, PowerPoint, Architectural Drawings, Working Drawings, Perspective Drawings
Dr. Andrea L Richardson, Boston MA - MD (Doctor of Medicine)
Specialties:
Cytopathology
Address:
BRIGHAM AND WOMENS HOSPITAL DEPARTMENT OF PATHOLOGY
75 Francis St, Boston 02115
(617) 732-4764 (Phone)
75 Francis St, Boston 02115
(617) 732-4764 (Phone)
Certifications:
Anatomic Pathology, 1997, Cytopathology, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
BRIGHAM AND WOMENS HOSPITAL DEPARTMENT OF PATHOLOGY
75 Francis St, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
75 Francis St, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
Education:
Medical School
University of North Carolina At Chapel Hill
Graduated: 2013
University of Texas Southwestern Medical Center At Dallas
Graduated: 1992
Brigham and Women's Hospital
University of North Carolina At Chapel Hill
Graduated: 2013
University of Texas Southwestern Medical Center At Dallas
Graduated: 1992
Brigham and Women's Hospital
Andrea L Richardson, Brookline MA
Specialties:
Pathologist
Address:
111 Cypress St, Brookline, MA 02445
75 Francis St, Boston, MA 02115
75 Francis St, Boston, MA 02115
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology), American Board of Pathology Sub-certificate in Cytopathology (Pathology)
Andrea Lynn Richardson, Boston MA
Specialties:
Pathology, Anatomic Pathology, Cytopathology
Work:
Brigham & Women's Hospital
75 Francis St, Boston, MA 02115
75 Francis St, Boston, MA 02115
Education:
The University of Texas Southwestern (1992)
Compositions, Kits, And Methods For Predicting Anti-Cancer Response To Anthracyclines
US Patent:
2012005, Mar 1, 2012
Filed:
Aug 10, 2011
Appl. No.:
13/206829
Inventors:
Andrea L. Richardson - Chestnut Hill MA, US
Zhigang C. Wang - Chestnut Hill MA, US
Zhigang C. Wang - Chestnut Hill MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 39/395, C40B 30/04, G01N 33/566, A61P 35/00, A61K 31/704, C07H 21/00, C07K 16/18, C07H 21/02, C12Q 1/68, A61K 31/713
US Classification:
4241741, 435 611, 435 612, 506 9, 435 79, 4241781, 514 44 A, 514 34, 536 243, 5303897, 536 245
Abstract:
The present invention is based, in part, on the discovery that amplification of human chromosome 8q22-23 regions and over-expression of 8q22-23 genes (e.g., LAPTM4B and YWHAZ) is associated with and predictive of resistance to anthracycline-type chemotherapy. Accordingly, the invention relates to compositions, kits, and methods for predicting the response of cancer cells, e.g., breast, prostate, lung, ovarian, pancreatic, liver, and colon malignancies to anthracyclines.
Methods For Predicting Anti-Cancer Response
US Patent:
2013028, Oct 24, 2013
Filed:
Aug 19, 2011
Appl. No.:
13/818425
Inventors:
Andrea L. Richardson - Chestnut Hill MA, US
Zhingang C. Wang - Newton MA, US
Daniel P. Silver - Wayland MA, US
Zoltan Szallasi - Boston MA, US
Nicolai Juul Birkbak - Copenhagen, DK
Aron Charles Eklund - Copenhagen, DK
Zhingang C. Wang - Newton MA, US
Daniel P. Silver - Wayland MA, US
Zoltan Szallasi - Boston MA, US
Nicolai Juul Birkbak - Copenhagen, DK
Aron Charles Eklund - Copenhagen, DK
Assignee:
DANA-FARBER CANCER INSTITUTE, INC. - Boston MA
THE TECHNICAL UNIVERSITY OF DENMARK - Lyngby
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
THE TECHNICAL UNIVERSITY OF DENMARK - Lyngby
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
International Classification:
C12Q 1/68
US Classification:
506 9, 435 611
Abstract:
The present invention is based, in part, on the identification of novel methods for defining predictive biomarkers of response to anti-cancer drugs.